Sort by
Refine Your Search
-
Employer
-
Field
-
four years of beginning the position. The department will provide support with language learning. Eligibility The applicant must meet the following eligibility requirements: PhD and the qualifications
-
or Mathematics with the research profile in Statistics and Data Science, or a PhD degree in Applied Mathematics or Computer Science that is accompanied by the main research profile in Data Science. Very good oral
-
through the University’s Swedish language courses for new international staff. For your move to Sweden, we offer you continuous support through our relocation services. If you are accompanied by family
-
computational tools. Since a significant part of the teaching at the undergraduate level is in Swedish, the employee is expected to actively work to achieve sufficient language skills in Swedish for teaching
-
are coursework and 150 credits are devoted to the thesis. The following link provides additional information about our doctoral studies: https://lnu.se/en/research/PhD-studies/business-administration/ The
-
Project description Third-cycle subject: Biotechnology We are seeking a motivated PhD student to join our lab at KTH/SciLifeLab in Stockholm, focusing on precision medicine and cancer progression
-
KTH Royal Institute of Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health Project description Third-cycle subject: Medical Technology (Joint KTH-KI program) In
-
Swedish through the University’s Swedish language courses for new international staff. We offer you support for the move to Sweden. If you have a family, they will find new contacts and support through
-
learning in higher education and also get the opportunity to learn Swedish through the University’s Swedish language courses for new international staff. We offer you support for the move to Sweden. If you
-
Project description Third-cycle subject: Biotechnology We are seeking a motivated PhD student to join our lab at KTH/SciLifeLab in Stockholm, focusing on precision medicine and cancer progression